Ausginin 500 Nam Ha treats liver diseases that cause hyper ammonia in the blood (6 blisters x 10 tablets)
Dosage form Box of 6 blisters x 10 tablets
Specifications L-Ornithine-L-ASPARTATE
Ingredient Fatty liver, cirrhosis, liver coma, acute hepatitis, chronic hepatitis, tendonitis
Ingredient
| Composition information | Content |
| L-Ornithine-L-ASPARTATE | 500mg |
Uses
indications
Ausginin 500 is indicated in the following cases:
In blood ammonia conditions in some liver diseases, especially in the cerebral brain syndrome.
Pharmacokological
L - Ornithin L - Aspartat preparations are used to increase ammonia convert into urea and glutamin.
This is a dual salt complex, different from drugs containing only L - Ornithin, when entering the body, this compound dissociates into two amino acids, Ornithin and Aspartat. These two amino acids are raw materials involved in the urea cycle and glutamine synthesis. Urea is synthesized in the liver through the Ornithin cycle thanks to two key enzymes: Ornithine carbamoyl transferase and carbamoyl phosphate synthetase.
Glutamine synthesis is also held in the liver, for patients with amino acids, aspartat and dicarboxylate, including the ornithin cycle absorbed into the cell and adjust the amount of ammonia thanks to the glutamine synthesis.
Animal research also shows that L - Ornithin L - Aspartat has the effect of reducing ammonia content due to accelerating the glutamine synthesis. Therefore, the combination of L - Ornithin and L - Aspartat has a similar effect in the process of reducing ammonia levels, thus detoxifying and protecting liver cells.
Dynamic pharmacokinetics
Sell waste time of Ornithin and Aspartat shortly 0.3 - 0.4 hours. A small part of Aspartate is excreted via urinary tract.
Before taking Ausginin 500 Nam Ha treats liver diseases that cause hyper ammonia in the blood (6 blisters x 10 tablets)
How to use and dose
Adults: 2 capsules/time x 3 times/day.
The dose can be adjusted according to the patient's age and symptoms.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?
The drug is not at risk.
When using an overdose, consult your doctor.
What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.
Side Effects
When using Ausginin 500, you may experience unwanted effects (ADR).
Rare, 1/10000 Digestive: slightly disturbed in the gastrointestinal tract such as discomfort, slightly nausea. Instructions on how to handle ADR No need to stop treatment, these symptoms will disappear when the drug is discontinued. When there are unwanted effects, please notify your doctor. If you need more information, please consult your doctor or pharmacist.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Ausginin 500 contraindicated in the following cases:
People with renal failure.
Caution when using
Caution conditions when taking the drug: right in the first dose, if there are signs of severe and sudden drug allergy (anaphylaxis, quincke facial disease) are manifested through the following symptoms: chest tightness, dizziness, nausea, fainting or dizziness when standing up. These signs appear, you must immediately stop the medicine and see the doctor immediately.
The ability to drive and operate machinery
No driving and operating machinery while using ausginin.
Pregnancy
Consider the benefits and risks to use.
The period of breastfeeding
Consider the benefits and risks to use.
Drug interaction
There is no data on drug interaction.
Storage
In a dry place, avoid light, temperature not exceeding 30 ° C.
Other drugs
- CEPOREX TABLETS 500MG
- CINNARIZINE 15MG TABLETS
- GLICLAZIDE 40MG TABLETS
- Latuda
- PARIET 20MG GASTRO-RESISTANT TABLETS
- STEROFUNDIN ISO SOLUTION FOR INFUSION
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions